Home > Patients > Post-Treatment
Post-Treatment
Will I be Incontinent?
In the first patients treated with Ablatherm® HIFU approximately
1 in 12 experienced either Type 1 or Type 2 incontinence. Type
1 incontinence is the leakage of urine with marked straining.
Type 2 is the leakage of urine with mild to moderate straining.
Both types of incontinence are manageable with medications and
pelvic floor exercises and, if present, last only one month on
average. Fortunately, in almost all cases these types of incontinence
are temporary. Recent advancements in Ablatherm® HIFU have
resulted in even fewer cases of initial Type 1 and Type 2 incontinence.
Importantly, there are essentially no total, severe incontinence
cases (Type 3) reported unless patients have had previous radiation
or surgery.
Will I be Impotent?
Forty percent of patients retain normal erectile function after
treatment. This compares favorably with patients undergoing radical
surgery. In those patients specifically treated with nerve sparing
techniques, erectile function is retained in over 80% of cases.
In addition, the majority of patients who suffer erectile dysfunction
following treatment by Ablatherm® HIFU will respond to oral
medications (Viagra, Levitra, Cialis). Peer reviewed journal
articles now support the use of these oral medications after
treatment to enhance healing. Fortunately, many patients regain
potency 6 to 12 months after treatment.
Do I Need Further Tests?
A quarterly measurement of the PSA is recommended for the first
two years, and biannual tests are recommended in years three
and four. Thereafter we recommend an annual PSA test. Three to
six months after the treatment the PSA should be reduced to almost
undetectable levels.
If the PSA level is undetectable, no prostate biopsy is necessary.
If the PSA reading does not return to very low levels, a repeat
ultrasound and biopsy can be performed. If this biopsy shows
residual tumor (approximately 3% of Canadian cases), a second
Ablatherm® HIFU session can be conducted. A major advantage
of Ablatherm ® HIFU is that it is repeatable and does not
preclude future treatment by any other treatment options. A bone
scan and Cat Scan would also be ordered. If biopsies are negative
but the PSA rises, additional therapy may be prescribed.
|